Source BioScience plc (LSE: SBS) the international diagnostics and genetic analysis business, today announces the following changes to the Group’s board of directors (the “Board”).
The Group is delighted to announce that Mr Robert Bakewell, Finance Director, will join the Board with immediate effect. Rob joined Source BioScience in 2005 and has been Finance Director of the Group, in a non-board capacity, since 2011. Rob converted the Group to IFRS and has overseen the consolidation of the finance function and associated systems as the Group has expanded. Rob qualified as a Chartered Management Accountant in 1996 and has over ten years of regulatory compliance and corporate activity experience for listed companies. Prior to joining the Group he was Financial Controller at DCS Group plc, which provided software solutions to global freight organisations and European motor retailers from subsidiaries in Europe and the USA.
After more than eight years of service as a Non Executive Director, Robin Slinger believes that it is now appropriate to step down from the Board. Since joining the Group in 2004, Robin has provided guidance and independent appraisal across the full spectrum of business matters and disciplines. Everyone at Source BioScience would like to thank Robin for his diligence, and input, and wish him all the best in his future endeavours.
Laurie Turnbull, Chairman, said: “I am very pleased to welcome Rob to the Board. His appointment will strengthen the range of financial and regulatory expertise available to the Board as it continues with the implementation of the Group’s growth strategy.”
There is no additional information required to be disclosed pursuant to paragraph 9.6.13 of the Listing.